article thumbnail

Using next-gen CRISPR tool, scientists create unprecedented molecular map of human immune response

Science Daily: Pharmacology News

In a study of historic scale, scientists have created an intricate map of how the immune system functions, examining the detailed molecular structures governing human T cells using the next-generation CRISPR tool known as base editing.

article thumbnail

Scientists discover a cause of lupus and a possible way to reverse it

Science Daily: Pharmacology News

Scientists have discovered a molecular defect that promotes the pathologic immune response in systemic lupus erythematosus (known as lupus) and show that reversing this defect may potentially reverse the disease.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pfizer, BioNTech stumble in effort to develop combination flu, COVID shot

BioPharma Drive: Drug Pricing

The vaccine didn’t spur a strong enough immune response against a particular flu strain in a Phase 3 trial, leading the companies to ponder adjustments.

article thumbnail

Chlamydia Vaccine Shows Promise in Early Trial

Drugs.com

FRIDAY, April 12, 2024 -- A chlamydia vaccine has triggered immune responses in an early trial, raising hopes that one day it might help curb the spread of the sexually transmitted infection (STI).There There is currently no vaccine for chlamydia, which.

Vaccine 290
article thumbnail

Microarray patches safe and effective for vaccinating children, trial suggests

Science Daily: Pharmacology News

The first study of the use of microarray patches to vaccinate children has shown that the method is safe and induces strong immune responses.

Vaccine 305
article thumbnail

A dial for tuning the immune system: Discovery sheds light on why COVID makes some sicker than others

Science Daily: Pharmacology News

Researchers have discovered a protein variant that serves as a knob for regulating the body's innate immune response. The findings could lead to new therapies for Long COVID, autoimmune disorders, and more.

article thumbnail

New mRNA vaccine created to prevent and treat C. difficile

Science Daily: Pharmacology News

difficile first-time infections and relapsing infections by inducing a robust immune response, promote clearance of existing C. diff bacteria from the gut, and even overcome deficits in host immunity to protect animals after infection, according to researchers. In animal models, this first mRNA-LNP C.

Vaccine 309